Introduction
Like phenylketonuria, congenital hypothyroidism has apparently become a model condition for mass screening. Testing for congenital hypothyroidism was first introduced into a screening programme in Quebec in 1974,1 and a recent leading article in the BMY concluded that further delays in implementing a national screening programme for the condition in Britain cannot be justified.2 Untreated, congenital hypothyroidism leads to mental and physical retardation, and the disease is rarely diagnosed clinically before irreversible nervous system damage is established. Some three and a half million babies have now been screened for hypothyroidism, the worldwide case-detection rate being 1:4435 (Western Europe 1:3976, North America 1:4299, Australia 1:5817, Japan 1:6884).3 Hulse et al reported an incidence of 1:3363 among newborn infants in North London and adjoining counties.4 Detection of congenital hypothyroidism by thyroid-stimulating hormone (TSH) assay on dried-blood filter-paper specimens is a sensitive and practical procedure with a low recall rate. Confirmatory assays are in the repertoire of all endocrine laboratories and within the competence of general clinical laboratories experienced in radioimmunoassay. The efficacy of treatment-namely, simple oral replacement-has been proved, and mass screening and early institution of treatment will apparently be an economic asset to the community compared with maintaining untreated patients. 5 A national newborn blood phenylketonuria screening service for Ireland was established in the pathology department of the Children's Hospital in 1966, the Guthrie microbiological inhibition assay procedure being used on dried blood collected by heel stab on the fourth or fifth day of life.6 Similar tests have been added at intervals for other inherited metabolic errors, and the entire newborn population of Ireland is now screened for phenylketonuria, homocystinuria, galactosaemia, tyrosinaemia, maple syrup urine disease, and, since August 1979, hypothyroidism. The additional metabolite tests added little to the cost of testing for phenylketonuria, but capital and running costs were increased when screening for congenital hypothyroidism was included.
We describe the incorporation of screening for hypothyroidism into the national newborn dried-blood screening programme in the Republic of Ireland and present the results of a 12-month pilot study.
Materials and methods
The programme was funded by the Department of Health, and the 12-month pilot study was begun on 1 August 1979. The screening procedure consisted in estimating by radioimmunoassay thyroidstimulating hormone concentrations in heel-stab samples of dried blood. A steering committee was set up, comprising a medical representative from the Department of Health, paediatricians from centres throughout Ireland, a consultant endocrinologist and consultant radiologist, and the laboratory director and clinical biochemists concerned. One of us (SD) acted as secretary and clinical co-ordinator for the study. The committee met monthly to review laboratory results and case records and discuss protocol in relation to developments.
Collection of blood samples-Heel-stab samples are collected on filter paper before discharge from the maternity unit, the advice being that this should be done on the fourth day of life. Specimens are collected from all newborn in the Republic of Ireland. Screening for hypothyroidism necessitated adding a further circle for blood on the collecting card to prevent overspotting; for although this and consequent supersaturation of the filter paper is acceptable for the microbiological assays, it results in misleadingly high TSH concentrations and hence a high recall rate.
Laboratory organisation-The organisation of the screening programme has been described. 7 The screening laboratory is sited in the hospital pathology department and supervised by SFC. Thyroid hormone assays had not been carried out before, though the laboratory was experienced in radioimmunoassay procedures. A special small laboratory was established immediately adjacent to the main laboratory. A basic-grade biochemist was appointed but screening staff were not increased; other biochemistry personnel were trained in the procedure to serve as relief staff. Discs are hand punched from blood specimens into tubes before being transferred in racks to the radioimmunoassay laboratory. Some 300 specimens are assayed daily during Monday to Friday.
Radioimmunoassay-A commercial solid-phase kit method (Phadebas dry-spot TSH test, Pharmacia Diagnostics, Uppsala) is used on a 4-25 mm disc punched from the filter paper. The discs are eluted for four hours with 0-05 ml Sephadex-anti-TSH complex and incubated overnight after the addition of 0-1 ml 151I-labelled TSH. 
Results
During the pilot study 76 224 infants were screened; 50 (0 07%) were recalled for a serum sample and 19 cases of congenital hypothyroidism were confirmed, giving an incidence of 1:4012. In the 19 confirmed cases the first blood spot was collected between days 3 and 11. Initial testing was conducted between days 5 and 15 and (in 18 cases) confirmatory serum testing between the 10th and 23rd days (in case 3 testing was delayed by administrative problems). Table II shows the distribution of dried blood-spot TSH concentrations in the series. Only 447 infants (0-06%) had values exceeding 20 mU/l and 33 (0-04%) values exceeding 40 mU/l on initial assay. Table III gives the TSH and thyroxine concentrations in the confirmed cases.
The recall rate (0 07%) was remarkably low. Nevertheless, the rate was higher in the early months (0-16%), probably owing to technical problems and faults in the collection technique-for example, over- During the last four months of the study pertechnetate thyroid scan was included in the protocol to confirm the diagnosis. Ten infants were scanned, resulting in diagnoses of agenesis in two, ectopic thyroid in six, hypoplastic gland in one, and unilateral thyroid gland with normal uptake in one. This last infant (case 12), who presented as a clinically normal child with raised TSH and normal thyroxine concentrations, was regarded as an example of transient hyperthyrotrophinaemia and required long-term follow-up only.
Congenital hypothyroidism had apparently not been suspected clinically in any of the affected infants before recall. Nevertheless, at the time of recall three infants (cases 6, 9, and 13) had obvious clinical features (serum thyroxine concentrations < 10, 60, and 28 nmol/l (<0 8, 4 7, and 2-2 gg/100 ml) respectively), including coarse facies, The aim of the programme is to prevent the sequelae of congenital hypothyroidism, and our priority has been to provide early diagnosis and begin treatment at the earliest opportunity. Wolter et al, 8 who studied the neuropsychological sequelae of treated thyroid dysgenesis, tried to define the time of onset and duration of hypothyroidism for each child from bone age. They showed that by treating prenatal hypothyroidism before 1 month of age the IQ was reversed to normal, but minor neuropsychological defects remained. These were also present in infants with postnatal onset of hypothyroidism, who were all shown to have a normal IQ. Their earliest-treated child was 18 days old, and they commented that better results may be expected from earlier treatment, which should be possible for children detected by a well-organised screening programme.
The mean age at beginning treatment in this study(15 days) was half that in the study reported by Hulse et al4 In the Irish programme the diagnosis is accelerated by the earlier age at heelstab sampling (4-6 days), by carrying out assays five days a week, and by recalling the infant for a serum sample when the bloodspot TSH value exceeds 40 mU/l, such samples being processed as an emergency. The low recall rate justifies this procedure. The only unavoidable delay is postal, which occurs occasionally in the delivery of blood cards. The effectiveness of early testing and rapid follow-up in the Irish screening programme was referred to by Starfield and Persistence with a programme of fitness training depends largely on the certainty that success will be possible and on the presence of signs that improvement is occurring rapidly. For all but children and healthy young adults, exercise challenge should be gradual and unobtrusive3 and medically supervised.4 Analysis of motivational factors leading to participation in vigorous physical training has shown that a desire to keep fit and to achieve a subjective feeling of well being is the most important.3 It is known, however, that positive attitudes towards physical education are not necessarily correlated with high scores of physical fitness.6
In the case of adolescents and young adults, motivation is quickly lost if results are not achieved. "How long does it take to get fit?" is thus an important question that the doctor is asked whenever he recommends that an individual start a training programme. I report here the results of a study to answer this question in subjects of both high and low initial motivation.
Methods
Background-This study was undertaken during routine training in an annual army camp (Army Reserve) of 16 days' duration. Test subjects comprised 50 healthy male students aged 18-24 years.
Physicalfitness programme-A standard 10-station training circuit' 8 was established. Each station consisted of a standard physical task (Harvard step test, "chin-up" horizontal bar, body-press site, etc). Subjects set their own initial task baselines in standard fashion. 4 The fitness programme then consisted of three sequential circuits of the 10-station course, at maximum speed against a stopwatch. Each individual undertook the training session twice daily for 14 consecutive days, under close supervision. Course times varied from eight to 14 minutes (see fig 1) . Unlike other combat conditioning courses,8 subjects in this study were not involved in other strenuous physical activities during the duration of the tests. Normal warm-ups were
